Dr Rebecca Pinto: Scrolling towards a happy, healthy life
The physiotherapist, nutritionist and founder of the Ace Vitals brand has quickly amassed over 400,000 followers on Instagram as a wellness content creator.
Dr. Rebecca Pinto
By Asjad NazirSep 20, 2024
DR REBECCA PINTO recognised a shift towards wellness during the Covid lockdown and used her expertise to help others lead happier and healthier lives.
The physiotherapist, nutritionist and founder of the Ace Vitals brand has quickly amassed over 400,000 followers on Instagram as a wellness content creator.
Her viral reels include one titled Is kissing better than walking on a treadmill? which amassed 33 million views. With her quirky videos, blending fun with health education, Pinto has helped turn mindless social media scrolling into something more beneficial.
Eastern Eye caught up with the all-round wellness expert to discuss her inspiring content creation journey and top health tips. She also spoke about the benefits of kissing, the role of vitamins in one’s hair colour and raising awareness about men’s health.
What connected you to health and nutrition?
I first got into nutrition because of my own health struggles. I weighed 98kg and realised that my health was deteriorating when I couldn’t even climb a flight of stairs. That was my wake-up call. I began studying nutrition and realised I could educate myself through courses, which is what initially connected me to health and nutrition.
What made you want to share your knowledge on good health as a content creator?
The lockdown was a major turning point. Many people couldn’t visit doctors due to Covid, so I started offering online consultations. It became clear there was a significant lack of awareness about health, so I decided to create videos. This not only helped spread knowledge, but also led to more consultations.
Which of your reels have been your favourite?
My earlier reels, where I blended fun with education, are my favourites. I enjoyed making them because they were unique and educated people while also entertaining them.
Where do you get your ideas from?
Everywhere – sometimes, I get them while driving or listening to a song, where the lyrics spark an idea. Often, I’m inspired by my patients’ experiences or conversations with friends. Ideas truly come from various sources.
Do you think people have become more aware of their health since the pandemic?
Absolutely. The pandemic has significantly increased health awareness. People are now more informed about the importance of sleep, diet and overall lifestyle than ever before.
What’s a top health tip you would give?
The importance of eight to nine hours of quality sleep is often underestimated. Good sleep solves most health issues and is crucial for overall well-being, yet many people don’t fully realise how truly vital and transformative it is.
How important is it to pay attention to food intake?
As you age, it becomes extremely important. When you’re young, your body can handle almost anything, but as you get older, your body starts to degenerate. Proper nutrition slows down this degeneration. Think of it like a car – when it’s new, it runs well no matter how you drive it, but as it ages, you need to take better care of it.
What are great superfoods?
There’s really no such thing as superfoods. Some foods are more nourishing than others, but the concept of a superfood is a myth. Take moringa, for example, it’s highly nutritious, but it’s not a cure-all. It’s currently trending, but it should be consumed in moderation.
What is a good mental health tip?
Again, sleep is crucial. Recent studies suggest that regardless of your natural sleep pattern, going to bed by 10-11pm and getting the majority of your sleep before midnight is highly beneficial for mental health. While meditation is important, sleeping on time can make a significant difference.
Your reels cover topics not normally discussed. Is it true that kissing and cuddling can promote good health?
Yes, they do. Kissing and cuddling promote the release of happy hormones and provide a sense of comfort and support, which contributes to better mental health and overall well-being.
You did a series of reels on men’s health. Do you think men pay less attention to their health and should that change?
I created the men’s health series because men often neglect their health. They tend to dismiss symptoms and avoid doctor visits, especially while focusing on their careers, putting their well-being at risk. Awareness about issues such as prostate cancer, mental health, and lifestyle diseases is still lacking. Men’s health is underrated, stigmatised, and needs much more attention, which is why I started that series to promote education and open conversations.
You did a reel about some foods preventing grey hair. Does that work?
Yes, food can prevent premature greying. While age and genetics are unavoidable factors, early greying results from stress, which depletes the levels of vitamins B12 and D. Ensuring these vitamins are maintained can delay greying.
However, greying due to age or heredity cannot be reversed, but food can help if the cause is stress or deficiency.
What inspires you?
The results of my work inspire me. Whether it’s a patient feeling better after physiotherapy, someone losing weight through my diet plans, or a reel gaining traction and shares – the positive impact and value of my work drive me to keep going.
A deep cut from Connie Francis’ 1962 catalogue is suddenly back in the spotlight, thanks to a viral trend on TikTok. Pretty Little Baby, a track from her album Connie Francis Sings Second Hand Love, has captivated a new generation of fans over six decades after its original release.
Unlike her chart-topping hits such as Everybody’s Somebody’s Fool or Don’t Break the Heart That Loves You, Pretty Little Baby was never released as a single. But today, it’s enjoying a second life online. TikTok users have embraced the romantic tune, using it in more than a million videos. Many creators are seen lip-syncing the line “You can ask the flowers / I sit for hours / Telling all the bluebirds / The bill and coo birds / Pretty little baby, I’m so in love with you” – often while dressed in retro-style outfits or serenading real babies.
- YouTubeYouTube / LEO MARK TELEG
The social media buzz has translated into a dramatic surge in streaming numbers. In the week ending 10 April, the song recorded just 17,000 on-demand streams in the US. Four weeks later, that number skyrocketed to 2.4 million – a jump of over 7,000%. It has since entered Spotify’s Daily Top Songs charts in both the US and globally, and could soon make an appearance on the Billboard Hot 100 for the very first time.
Francis was one of the biggest pop stars of the late 1950s and early ’60s, scoring 15 top ten hits on the Billboard Hot 100. Although Pretty Little Baby didn’t chart during her heyday, the song’s timeless melody and sweet lyrics are striking a chord with today’s audiences.
The track’s sudden popularity underlines how vintage songs can enjoy fresh success in the digital age. For many, the charm of Pretty Little Baby lies in its simplicity – a gentle, heartfelt tune with lyrics that still resonate.
For longtime fans and first-time listeners alike, the revival of Pretty Little Baby is a reminder of Connie Francis’ enduring appeal and the surprising ways in which classic music can resurface – even 63 years later.
A new community-led initiative has been launched in the UK to provide culturally sensitive support for South Asian women navigating midlife and menopause.
The Sattva Collective, founded by certified Midlife and Menopause Coach Kiran Singh, officially launched on 14 May 2025 as a registered Community Interest Company (CIC). It is the first initiative in the UK focused specifically on the experiences of South Asian women during what Singh describes as a “deeply personal and often stigmatised” phase of life.
“South Asian women are navigating physical, emotional, and identity shifts in silence – often without the language, space, or support to talk about it,” Singh said. “The Sattva Collective is here to change that. We are reclaiming midlife as a powerful, transformative time – and doing it together.”
The name 'Sattva' is drawn from Sanskrit, referring to clarity, balance, and inner peace – values reflected in the collective’s approach.
The organisation will offer a range of services throughout the year, including:
Monthly community meet-ups in local cafés
Educational workshops on hormone health, mental well-being, and cultural stigma
An annual flagship Midlife Summit launching in January 2026
Public awareness campaigns and digital resources
One-to-one and group coaching sessions
Singh, who is of Indian heritage, aims to address the gaps in both mainstream and cultural conversations around menopause. According to her, many South Asian women face barriers to accessing support due to stigma, lack of awareness, and limited representation in public discourse.
The Sattva Collective is now preparing to roll out its 2025 programme and is actively seeking funding, sponsorship, and community partners to expand its reach and resources.
Describing midlife as “not a crisis, but a calling,” Singh hopes the initiative will empower more women to speak openly about their health and experiences, while building a supportive community.
Further details about upcoming events and resources will be made available through the collective’s official channels in the coming weeks.
Keep ReadingShow less
Bella Hadid stuns at the Cannes Film Festival 2025 in a daring Saint Laurent black gown
Bella Hadid’s return to the Cannes Film Festival was anything but quiet. This year, the model showed up ready to challenge the red carpet rules without actually breaking them.
With new restrictions in place like no sheer fabrics, no visible nudity, no dramatic trains or bulky silhouettes, fashion-watchers wondered if Bella, known for her daring Cannes looks in the past, would tone it down. Instead, she found a clever way around the rules.
Her choice for the opening ceremony? A sleek black Saint Laurent dress with a high slit that climbed nearly to her hip. It was revealing but not banned. The asymmetrical cowl neckline and bare back added to the drama without crossing any lines. Paired with barely-there strappy heels, emerald statement earrings, and a ring, the outfit managed to be both understated and provocative.
Earlier in the day, she’d already turned heads arriving at Hotel Martinez in a white corset top and matching bootcut trousers, another Saint Laurent nod. Her honey-blonde updo, oversized sunglasses, and vintage accessories made it clear that Bella wasn’t here to just blend in.
And while the Met Gala missed her this year, Cannes got the full Hadid effect.
The model’s new hair colour, a shift from brunette to a summery honey blonde, felt like a fresh chapter. Soft waves framed her face, complementing the dark, moody tones of her red carpet outfit. Makeup stayed simple with smokey eyes, matte skin, and nude lips. No theatrics, pure elegance and confidence.
The most impressive part of it all? She managed to follow every rule while still standing out. While some stars played it safe under the stricter dress code, Bella turned the limits into a challenge. No sheer panels? Try bold cut-outs. No dramatic trains? Go for shape-hugging minimalism with impact.
Fashion at Cannes has always been about pushing boundaries. This time, Bella Hadid did it with precision, walking the tightrope between compliance and creativity.
A nationwide recall of five eye care products has been issued in the United States after concerns were raised about their sterility and manufacturing standards. BRS Analytical Services, LLC, the manufacturer of the affected products, has urged consumers to stop using them immediately due to potential safety risks.
The recall, shared in a press release by healthcare distributor AvKARE, affects more than 1.8 million cartons of eye drops. The US Food and Drug Administration (FDA) identified multiple violations during a recent audit, including failures to meet Current Good Manufacturing Practice (CGMP) standards.
CGMP regulations set the minimum requirements for the manufacturing, processing, and packaging of drug products to ensure their safety, quality, and efficacy. The FDA stated there is a “lack of assurance of sterility” in the recalled items, which could pose serious health risks to users.
The following products have been included in the recall:
Artificial Tears Ophthalmic Solution
Carboxymethylcellulose Sodium Ophthalmic Gel 1%
Carboxymethylcellulose Sodium Ophthalmic Solution
Lubricant Eye Drops Solution
Polyvinyl Alcohol Ophthalmic Solution
Although the company has not specified the exact health risks, it warned that the products are of “unacceptable quality” and that “it’s not possible to rule out patient risks resulting from use of these products.”
The recalled products were distributed from 26 May 2023 to 21 April 2025. Consumers in possession of any of the affected items are advised to discontinue use immediately and either return them to the place of purchase for a full refund or dispose of them safely.
Customers are also encouraged to complete and submit the recall notice form, including the “Quantity to Return” section and their contact details. These can be sent via fax or email to AvKARE, even if the products are no longer in their possession.
The FDA has categorised the recall as a Class II, meaning there is a reasonable probability that use of the products could result in temporary or medically reversible adverse health effects, or that serious harm is unlikely but possible.
Keep ReadingShow less
This may influence future decisions on treatment options for obesity patients
Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.
This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.
The results revealed that Zepbound helped nearly 25% more participants achieve a weight loss of over 15% compared to Wegovy. In addition, Zepbound demonstrated a more significant reduction in waist circumference, with an average decrease of 18.4 cm. In comparison, Wegovy participants saw an average reduction of 13 cm.
Novo Nordisk, in a statement sent via email on Monday, pointed out that the weight loss achieved by Wegovy in this trial was lower than what was observed in a 2021 trial with a similar dose. However, the company emphasised that Wegovy is the only GLP-1 agonist medicine approved to prevent major cardiovascular events, such as heart attacks, a critical benefit for patients with obesity. Novo also mentioned that a trial with a higher dose of semaglutide, Wegovy's active ingredient, conducted earlier this year, showed greater weight-loss results.
Lilly had previously reported in December that its obesity drug had already surpassed Wegovy, with patients treated with Zepbound losing 47% more weight than those who received Wegovy. These findings were also shared in a press release and presented at the European Congress on Obesity.
The timing of the trial results coincides with a recent decision by CVS Health to exclude Zepbound from some of its reimbursement lists, preferring Wegovy instead. This move highlights the ongoing competition between the two pharmaceutical giants in the obesity treatment space.
Zepbound mimics two gut hormones to support weight loss, while Wegovy relies on a single mode of action. In separate trials, Lilly's Zepbound helped patients lose more than 22% of their body weight after 72 weeks, while Wegovy led to a 15% reduction in weight after 68 weeks.
The growing competition in the weight-loss drug market is also impacted by another Eli Lilly medication, Mounjaro, which has shown positive results for diabetes and weight loss. With these advancements, Eli Lilly is positioning itself as a major player in the obesity treatment landscape.
These results reflect the growing rivalry in the weight-loss drug market and may influence future decisions on treatment options for obesity patients.